Incidence and risk factors of venous and arterial thromboembolic events among patients with ovarian cancer- data from a large Canadian database

CONCLUSIONS: Risk factors predictive of thrombosis in ovarian cancer patients are not consistent between ATE and VTE, thus thrombotic events should not be combined for analysis. Differential thrombosis risk assessment is needed to improve prevention strategies and guide thromboprophylaxis for these patients.PMID:38382168 | DOI:10.1016/j.ygyno.2024.02.011
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Source Type: research